Literature DB >> 23330876

Probing a chemical space for fragmental topology-activity landscapes (FRAGTAL): application for diketo acid and catechol HIV integrase inhibitor offspring fragments.

Andrzej Bak1, Tomasz Magdziarz, Agata Kurczyk, Katarzyna Serafin, Jaroslaw Polanski.   

Abstract

Fragmental topology-activity landscapes (FRAGTAL), a new concept for encoding molecular descriptors for fragonomics into the framework of the molecular database records is presented in this paper. Thus, a structural repository containing biological activity data was searched in a substructure mode by a series of molecular fragments constructed in an incremental or decremental manner. The resulted series of database hits annotated with their activities construct FRAGTAL descriptors encoding a frequency of the certain fragments among active compounds and/or their activities. Actually, this method might be interpreted as a simplified adaptation of the frequent subgraph mining (FSM) method. The FRAGTAL method reconstructs the way in which medicinal chemists are used to designing a prospective drug structure intuitively. A representative example of the practical application of FRAGTAL within the ChemDB Anti-HIV/OI/TB database for disclosing new fragments for HIV-1 integrase inhibition is discussed. In particular, FRAGTAL method identifies ethyl malonate amide (EMA) as the diketo acid (DKA) related arrangement. Since new molecular constructs based on the EMA fragment are still a matter of future investigations we referred to this as anthe DKA offspring.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330876     DOI: 10.2174/1386207311316040002

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  1 in total

1.  SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors.

Authors:  Andrzej Bak; Hana Pizova; Violetta Kozik; Katarina Vorcakova; Jiri Kos; Jakub Treml; Klara Odehnalova; Michal Oravec; Ales Imramovsky; Pavel Bobal; Adam Smolinski; Zdeněk Trávníček; Josef Jampilek
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.